MYARTA Trademark

Trademark Overview


On Tuesday, June 1, 2021, a trademark application was filed for MYARTA with the United States Patent and Trademark Office. The USPTO has given the MYARTA trademark a serial number of 79314844. The federal status of this trademark filing is REGISTERED as of Tuesday, June 14, 2022. This trademark is owned by NOVARTIS AG. The MYARTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system, and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for medical use, namely pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treatment of gastroenterological diseases and disorders, biological preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treatment of gastroenterological diseases and disorders; pharmaceutical and biological preparations for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune d...
myarta

General Information


Serial Number79314844
Word MarkMYARTA
Filing DateTuesday, June 1, 2021
Status700 - REGISTERED
Status DateTuesday, June 14, 2022
Registration Number6756398
Registration DateTuesday, June 14, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 29, 2022

Trademark Statements


Goods and ServicesPharmaceutical and biological preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system, and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for medical use, namely pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treatment of gastroenterological diseases and disorders, biological preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treatment of gastroenterological diseases and disorders; pharmaceutical and biological preparations for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; pharmaceutical and biological preparations, namely, anti-fungal, anti-infective, antiviral and antibiotic preparations.''

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events


Event DateEvent Description
Tuesday, September 27, 2022FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, September 27, 2022FINAL DISPOSITION PROCESSED
Wednesday, September 14, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 14, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 14, 2022REGISTERED-PRINCIPAL REGISTER
Monday, April 4, 2022NOTIFICATION PROCESSED BY IB
Tuesday, March 29, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 29, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 9, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 9, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, January 22, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 21, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 10, 2022ASSIGNED TO EXAMINER
Tuesday, November 23, 2021REFUSAL PROCESSED BY IB
Sunday, October 24, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, October 21, 2021REFUSAL PROCESSED BY MPU
Tuesday, September 28, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 27, 2021NON-FINAL ACTION WRITTEN
Monday, September 20, 2021ASSIGNED TO EXAMINER
Monday, August 16, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 16, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, August 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 16, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 20, 2021APPLICATION FILING RECEIPT MAILED
Thursday, July 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 12, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 1, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB